Amylyx Pharmaceuticals, Inc. AMLX Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Amylyx Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s quick ratio?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported quick ratio of 17.9× in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s quick ratio changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s quick ratio increased by 48.1% year-over-year, from 12.1× to 17.9×.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s quick ratio?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s quick ratio has grown at a 24.0% compound annual growth rate (CAGR), from 6× to 14.3×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.